Last updated 16 days ago
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
60 patients around the world
Available in Argentina
Janssen Research & Development, LLC
5Research sites
60Patients around the world
This study is for people with
Arthritis
Psoriasic arthritis
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Sites
STAT Research - CABA
Recruiting
Centro Médico Privado de Reumatología - San Miguel de Tucumán
Recruiting
Hospital de Niños de la Santísima Trinidad - Córdoba
Recruiting
Instituto Médico Platense SA - La Plata
Recruiting
Instituto CAICI - Rosario, Santa Fe
Recruiting
StudyPSUMMIT-Jr
SponsorJanssen Research & Development, LLC
Study typeInterventional
Conditions
Psoriasic arthritis
Requirements
To 17 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05083182
